NeuroCatch® is an innovative player in the Biotechnology and Medical Devices industries, offering a breakthrough solution for assessing brain function. Founded in 2015 and headquartered in Canada, the company is gaining attention for its industry-leading medical device—The NeuroCatch® Platform.
Known for its concise slogan, "The NeuroCatch® Platform is a rapid, objective, neuro-physiological brain function assessment system. 🧠," the platform provides a swift and objective evaluation of cognitive function, facilitating assessments in mere minutes at the point of care. With its ease of use, portability, and accessibility, it holds a Health Canada Class II medical device license, ensuring both reliability and compliance with rigorous standards.
While the company has yet to secure its last publicized investment, its focus on cognitive function assessment technology positions it as an attractive opportunity in the health tech space. Investors might find NeuroCatch® an intriguing target for further exploration and funding consideration.